Recovery From COVID-19-Related Disruptions in Cancer Detection.

ABSTRACT:

Importance

The COVID-19 pandemic impacted the timely diagnosis of cancer, which persisted as the second leading cause of death in the US throughout the pandemic.

Objective

To evaluate the disruption and potential recovery in cancer detection during the first (2020) and second (2021) years of the COVID-19 pandemic.

Design, setting, and participants

This cross-sectional study involved an epidemiologic analysis of nationally representative, population-based cancer incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program. Included patients were diagnosed with incident cancer from January 1, 2000, through December 31, 2021. The analysis was conducted in May 2024 using the April 2024 SEER data release, which includes incidence data through December

SUBMITTER: Kim U 

PROVIDER: S-EPMC11474412 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature